FDA Keeps Its User Fees, but Fails to Gain Important Reforms
PharmExec
OCTOBER 6, 2022
The ‘skinny’ user fee reauthorization tables multiple high-profile proposals.
fda-keeps-its-user-fees-but-fails-to-gain-important-reforms 
52 
FDA User Fees Reauthorized
PharmaTech
OCTOBER 5, 2022
FDA keeps its user fees but fails to gain important reforms.
Let's personalize your content